Cost-Effectiveness of the Third-Agent Class in Treatment-Naive Human Immunodeficiency Virus-Infected Patients in Portugal
AuthID
P-002-5EQ
P-002-5EQ
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service